ClinVar Genomic variation as it relates to human health
NM_000135.4(FANCA):c.3761_3762del (p.Glu1254fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000135.4(FANCA):c.3761_3762del (p.Glu1254fs)
Variation ID: 370466 Accession: VCV000370466.11
- Type and length
-
Microsatellite, 2 bp
- Location
-
Cytogenetic: 16q24.3 16: 89742803-89742804 (GRCh38) [ NCBI UCSC ] 16: 89809211-89809212 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Jan 7, 2017 Jun 17, 2024 Dec 19, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000135.4:c.3761_3762del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000126.2:p.Glu1254fs frameshift NM_000135.4:c.3761_3762delAG MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NM_000135.2:c.3761_3762del NM_001286167.3:c.3761_3762del NP_001273096.1:p.Glu1254fs frameshift NC_000016.10:g.89742804TC[3] NC_000016.9:g.89809212TC[3] NG_011706.1:g.78848AG[3] LRG_495:g.78848AG[3] LRG_495t1:c.3761_3762del - Protein change
- E1254fs
- Other names
- -
- Canonical SPDI
- NC_000016.10:89742802:CTCTCTCTC:CTCTCTC
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
FANCA | - | - |
GRCh38 GRCh37 |
4167 | 5325 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (5) |
criteria provided, multiple submitters, no conflicts
|
Dec 19, 2023 | RCV000411410.8 | |
See cases
|
Pathogenic (1) |
criteria provided, single submitter
|
Mar 20, 2020 | RCV002252108.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Mar 20, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
See cases
Affected status: yes
Allele origin:
germline
|
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
Accession: SCV002523596.1
First in ClinVar: Jun 09, 2022 Last updated: Jun 09, 2022 |
Comment:
ACMG classification criteria: PVS1, PS4, PM2
Clinical Features:
Seizure (present) , Neurodevelopmental abnormality (present)
Geographic origin: Brazil
|
|
Pathogenic
(Aug 16, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
Fanconi anemia complementation group A
Affected status: unknown
Allele origin:
unknown
|
Counsyl
Accession: SCV000485796.2
First in ClinVar: Jan 07, 2017 Last updated: Dec 24, 2022 |
|
|
Pathogenic
(Mar 15, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Fanconi anemia complementation group A
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV002811719.1
First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022 |
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
Fanconi anemia complementation group A
(X-linked dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Lifecell International Pvt. Ltd
Accession: SCV003845980.1
First in ClinVar: Apr 01, 2023 Last updated: Apr 01, 2023 |
Comment:
A Heterozygous Frameshift variant c.3761_3762delAG in Exon 37 of the FANCA gene that results in the amino acid substitution p.Glu1254fs*23 was identified. The observed variant … (more)
A Heterozygous Frameshift variant c.3761_3762delAG in Exon 37 of the FANCA gene that results in the amino acid substitution p.Glu1254fs*23 was identified. The observed variant novel in gnomAD exomes and genomes, respectively. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score . Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Pathogenic (variant ID: 370466). This variant was reported among the patients for Fanconi Anemia (Levran O et al., 1997). Based on the above evidence this variant has been classified as Pathogenic according to the ACMG guidelines. (less)
Ethnicity/Population group: Asian
Geographic origin: India
|
|
Pathogenic
(Dec 19, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Fanconi anemia complementation group A
Affected status: unknown
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV004196028.2
First in ClinVar: Dec 30, 2023 Last updated: Jun 17, 2024 |
|
|
Pathogenic
(Feb 28, 2020)
|
no assertion criteria provided
Method: curation
|
Fanconi anemia complementation group A
Affected status: yes
Allele origin:
germline
|
Leiden Open Variation Database
Accession: SCV001425988.1
First in ClinVar: Sep 27, 2020 Last updated: Sep 27, 2020 |
Comment:
Curator: Arleen D. Auerbach. Submitters to LOVD: Arleen D. Auerbach, Sue Richards.
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
FANCA Gene Mutations with 8 Novel Molecular Changes in Indian Fanconi Anemia Patients. | Solanki A | PloS one | 2016 | PMID: 26799702 |
Sequence variation in the Fanconi anemia gene FAA. | Levran O | Proceedings of the National Academy of Sciences of the United States of America | 1997 | PMID: 9371798 |
Text-mined citations for rs868273545 ...
HelpRecord last updated Jun 17, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.